SCHEMBL4383785

SCHEMBL4383785

CCCC1CCC(C2CCC(C3=C(C(F)(F)F)c4c(F)cc(C)cc4C3)CC2)CC1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388855 0.87 TLR4 (0.32) TLR4
SCHEMBL4391852 0.71 TLR4 (0.34) TLR4
SCHEMBL13002675 0.67 CYP2C9 (0.40) TLR4
SCHEMBL13635336 0.67 GPR119 (0.35) TLR4
SCHEMBL17430790 0.67 CYP2C9 (0.42) TLR4
SCHEMBL12433696 0.66 HRH3 (0.33) TLR4
SCHEMBL4378638 0.66 MAOA (0.33) TLR4
SCHEMBL4383327 0.66 FYN (0.33)
SCHEMBL9120075 0.65 CYP2C9 (0.36) TLR4
SCHEMBL9120078 0.65 CYP2C9 (0.36) TLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409441-B1 INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY MERCK PATENT GMBH (DE) 2009-11-18 EP disclosed
US-7122228-B2 Transistros; liquid crystals display; electrooptics MERCK PATENT GMBH (DE) 2006-10-17 US disclosed
US-20040171866-A1 Transistros; liquid crystals display; electrooptics MERCK PATENTGESELLSCHAFT (DE) 2004-09-02 US disclosed
EP-1409441-A1 INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY MERCK PATENT GmbH (DE) 2004-04-21 EP disclosed
WO-2003010120-A1 INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY MERCK PATENT GMBH (DE) 2003-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171866-A1 Transistros; liquid crystals display; electrooptics VCL, RIF1, IPO11 TLR4 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.